期刊文献+

免疫组化法检测结直肠癌错配修复基因蛋白结果分析 被引量:2

Analyze the expression of mismatch repair proteins in colorectal cancer by immunohistochemistry assay
下载PDF
导出
摘要 目的分析错配修复基因(MMR)蛋白采用免疫组化法的检测结果,探讨其与结直肠癌的关系。方法用免疫组化法(IHC)对4种MMR蛋白进行检测,MLH1、PMS2、MSH2、MSH6均表达者为错配修复完整(p MMR),有一种以上及以上错配修复基因蛋白表达缺失为错配修复缺陷(dMMR)。结果 96例结直肠癌标本中,pMMR者85例(88.5%),dMMR者11例(11.5%);MMR蛋白缺失与CRC在发病部位和淋巴结转移方面有差异(P<0.05),在患者性别、发病年龄、肿瘤大小方面差异不明显(P>0.05)。结论结直肠癌的发病机制部分与MMR缺陷有关,且dMMR者好发于右半结肠,较少有淋巴结转移的病理特征。 Objective To detect the expression of mismatch repair proteins in colorectal cancer,and to analyze the correlation between MMR and pathologic features of colorectal cancer.Methods Immunohistochemistry(IHC)was used to detect four MMR proteins.All expression was classified as the MMR proficient(pMMR).Absent expression of one or more of these proteins was classified as the MMR deficient(dMMR).Results Among the 96 cases of colorectal cancer,85 cases were pMMR(88.5%)and 11 cases were dMMR(11.5%).Patients with MMR deficient CRC had difference in tumor location and lymph node metastasis(P<0.05).There was no obvious difference in gender,age,and tumor size(P>0.05).Conclusion The pathogenesis of colorectal cancer is related to MMR deficient,and dMMR is more common in the right semicolon,with less lymph node metastasis.
作者 管蕾 丁岚 Guan Lei;Ding Lan(The Jiangdu People's Hospital of Yangzhou City,Yangzhou,Jiangsu 225200)
出处 《基层医学论坛》 2019年第1期79-80,共2页 The Medical Forum
关键词 结直肠癌 错配修复基因蛋白 免疫组化 分析 Colorectal cancer Mismatch repair protein Immunohistochemistry Analysis
  • 相关文献

参考文献1

二级参考文献17

  • 1Steinke V, Engel C, Battner R, et al. Hereditary nonpolyposis colorectal cancer ( HNPCC)/Lynch syndrome [ J ]. Dtsch Arztebl Int, 2013,110(3) :32-38.
  • 2Palomaki GE, McClain MR, Melillo S, et al. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome[ J]. Genet Med, 2009, 11 (1) :42-65.
  • 3Vasen HFA, Watson P, Meeklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch Syndrome) proposed by the international collaborative group on HNPCC [ J ]. Gastroenteroloaw. 1999. 116 (6) , 1453-1456.
  • 4Berg AO, Armstrong K, Botkin J, et al. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives [J].Genet Med, 2009, 11(1) :35-41.
  • 5Jascur T, Boland CR. Structure and function of the components of the human DNA mismatch repair system [ J ]. Int J Cancer, 2006, 119(9) :2030-2035.
  • 6Edelbroek MA, Kaliyaperumal S, Williams KJ. Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noneanonieal activities[J]. Mutat Res, 2013, 743-744:53-66.
  • 7Nakagawa H, Lockman JC, Frankel WL, et al. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation [ J]. Cancer Res, 2004, 64 (14) :4721-4727.
  • 8Lynch HT, de la Chapelle A. Hereditary colorectal cancer[J]. N Engl J Med,2003, 348(10) : 919-932.
  • 9Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis eolorectal cancer) [ J ]. N Engl J Med, 2005, 352( 18 ) : 1851-1860.
  • 10Heald B, Plesec T, Liu X, et al. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center[ J ]. J Clin Oncol, 2013, 31 (10) :1336-1340.

共引文献7

同被引文献16

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部